Corona Virus Disease 19 (COVID-19) Patient Profile in Klungkung
Downloads
Introduction: Despite the effective global mass vaccination programs, which included booster shots, the emergence of new SARS-CoV-2 strains threatens to undo the enormous success achieved thus far in stopping its spread. This study aimed to assess the demographics of COVID-19 patients from February to May 2021.
Methods: Data were collected using secondary data from the medical records of Klungkung Regional General Hospital, Klungkung, at the time range according to the study period. Statistical Package for the Social Sciences (SPSS) version 25.0 for Windows and Microsoft Excel 2016 were used for the statistical analysis. All quantitative data, such as age, length of stay, and neutrophil-to-lymphocyte ratio (NLR), were estimated using central location measures (mean range). Proportions were used to describe qualitative or category variables.
Results: The demographic description of COVID-19 patients at Klungkung Regional General Hospital, Klungkung, found an average age of 51.94 years old. More patients were found to be male (55.4%) and did not have comorbidities (55.3%). Fourteen patients (14.4%) were gravid, and 37 patients (17.8%) were treated in the Intensive Care Unit (ICU). A total of 61 patients (29.3%) had desaturase with an NLR (mean) of 6.97 (51% increase). The average length of stay was 10.16 days, with the result of 24 patients dying (11.5%).
Conclusion: Patients with COVID-19 were found to have milder symptoms with less use of the ICU, not all of them experienced decreased saturation, and the case fatality rate was 11.5%.
Helmy YA, Fawzy M, Elaswad A, et al. The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. J Clin Med; 9. Epub ahead of print April 2020. [PubMed]
Wu F, Zhao S, Yu B, et al. A New Coronavirus associated with Human Respiratory Disease in China. Nature 2020; 579: 265–269. [PubMed]
Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed Atenei Parm 2020; 91: 157–160. [PubMed]
Nicola M, Alsafi Z, Sohrabi C, et al. The Socio-Economic Implications of the Coronavirus Pandemic (COVID-19): A Review. Int J Surg 2020; 78: 185–193. [PubMed]
Cascella M, Rajnik M, Aleem A, et al. Features, Evaluation, and Treatment of Coronavirus (COVID-19). Treasure Island (FL), 2023. [PubMed]
Hu C, Li J, Xing X, et al. The Effect of Age on the Clinical and Immune Characteristics of Critically Ill Patients with COVID-19: A Preliminary Report. PLoS One 2021; 16: e0248675. [PubMed]
Kolifarhood G, Aghaali M, Saadati HM, et al. Epidemiological and Clinical Aspects of COVID-19; A Narrative Review. Arch Acad Emerg Med 2020; 8: e41. [PubMed]
Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 Pathophysiology: A Review. Clin Immunol 2020; 215: 108427. [PubMed]
Liu Y, Mao B, Liang S, et al. Association between Age and Clinical Characteristics and Outcomes of COVID-19. The European Respiratory Journal; 55. Epub ahead of print May 2020. [PubMed]
Gesmalah M, Hidajah AC. Epidemiological Pattern of COVID-19 Infection from March to November 2020 in Situbondo District, East Java, Indonesia. Kesmas J Kesehat Masy Nas (National Public Heal Journal) 2021; 16: 23–28. [Journal]
Karyono DR, Wicaksana AL. Current Prevalence, Characteristics, and Comorbidities of Patients with COVID-19 in Indonesia. J Community Empower Heal 2020; 3: 77–84. [Journal]
Chatterjee S, Nalla LV, Sharma M, et al. Association of COVID-19 with Comorbidities: An Update. ACS Pharmacol Transl Sci 2023; 6: 334–354. [PubMed]
Iroungou BA, Mangouka LG, Bivigou-Mboumba B, et al. Demographic and Clinical Characteristics Associated with Severity, Clinical Outcomes, and Mortality of COVID-19 Infection in Gabon. JAMA Netw Open 2021; 4: e2124190. [PubMed]
Pálinkás A, Sándor J. Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study. Vaccines; 10. Epub ahead of print June 2022. [PubMed]
Soni SL, Kajal K, Yaddanapudi LN, et al. Demographic & Clinical Profile of Patients with COVID-19 at a Tertiary Care Hospital in North India. Indian J Med Res 2021; 153: 115–125. [PubMed]
de Lucena TMC, Santos AF da S, de Lima BR, et al. Mechanism of Inflammatory Response in Associated Comorbidities in COVID-19. Diabetes Metab Syndr 2020; 14: 597–600. [PubMed]
Sutaip S, Sutiningsih D, Adi MS, et al. Association between Comorbidities and COVID-19 Mortality: a Cross-Sectional Study in a Community Health Center in Indonesia. Int J Integr Heal Sci 2023; 11: 99–106. [Journal]
Bistara DN, Susanti, Setiawan AH, et al. Mortality of COVID-19 Patients with Comorbidity of Diabetes Mellitus: A Retrospective Study. Bali Med J 2023; 12: 2912–2916. [Journal]
Kim DW, Byeon KH, Kim J, et al. The Correlation of Comorbidities on the Mortality in Patients with COVID-19: An Observational Study Based on the Korean National Health Insurance Big Data. J Korean Med Sci 2020; 35: e243. [PubMed]
Radwan NM, Mahmoud NE, Alfaifi AH, et al. Comorbidities and Severity of Coronavirus Disease 2019 Patients. Saudi Med J 2020; 41: 1165–1174. [PubMed]
Copyright (c) 2024 Ni Komang Ari Sepriyanti, Erwin Winaya, I Wayan Ardyan Sudharta Putra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
JR (